Influenza News and Research

Latest Influenza News and Research

A study on the SARS-CoV-2 B.1.620 lineage

In a recently published Nature Communications study, the authors describe the B.1.620 lineage discovered in Lithuania.

27 Oct 2021

People with psychotic disorders at higher risk of hospitalization, death from infectious diseases

People with psychotic or bipolar disorders run a significantly higher risk of hospitalization and death from influenza, pneumonia or sepsis. This is what a new register study at Umeå University, Sweden, is showing.

27 Oct 2021

Sexually dimorphic placental antibody transfer during SARS-CoV-2 infection

In a paper recently published in the journal Science Translational Medicine by Bordt et al. (October 19th, 2021), maternal SARS-CoV-2 infections are studied with particular regard to maternal-fetal antibody transfer and virus-induced placental interferon responses, finding a sexually dimorphic response that results in lesser antibody transfer to the male fetus.

26 Oct 2021

How pregnancy influences SARS-CoV-2 immune response

A focus article published in Science Translational Medicine highlighted two recently published studies that investigated the response of pregnant women to natural infections and COVID-19 vaccines.

25 Oct 2021

Compared to influenza, COVID-19 is more likely to cause venous thrombosis

New research published in the medRxiv* preprint server suggests that COVID-19 illness incurs a greater 90-day risk of venous thrombosis than the flu. However, arterial thrombosis remains a higher risk among people with the influenza virus.

24 Oct 2021

Mapping the molecular gene signatures of respiratory viruses, including SARS-CoV-2

Researchers compare a large cohort of transcriptomic dataset maps of gene regulation by SARS-CoV-2 infection.

24 Oct 2021

Study shows immune profile heterogeneity amongst healthy adults

Researchers opted to use single-cell RNA-seq to observe single cells in detail as they encounter a specific antigen.

22 Oct 2021

Development of a safe and effective COVID-19 nanoparticle vaccine

Researchers from ReVacc scientific have attempted to demonstrate the effectiveness of a new vaccine, REVC-128, two weeks post-administration.

22 Oct 2021

Hydrogel-based vaccine delivery system evokes antibody response against SARS-CoV-2

Researchers from Stanford University have been attempting to create a hydrogel-based vaccine delivery system that could improve the immune response's strength and duration.

22 Oct 2021

Nationwide advertising campaign launches in the UK to urge people to get COVID-19 booster, flu jabs

A nationwide advertising campaign launches today (Friday 22 October) as part of the government's call to the public to get their COVID-19 booster and flu jabs, to protect themselves and their loved ones this winter.

21 Oct 2021

Comparison of social distancing policies in Denmark and Sweden to combat COVID-19

The current study included the national response of Denmark and Sweden to the COVID-19 pandemic.

21 Oct 2021

Duke awarded NIAID funding to develop the next generation of pan-coronavirus vaccines

The National Institute of Allergy and Infectious Diseases has awarded $17.5 million over three years to the Duke Human Vaccine Institute to develop a vaccine that protects against multiple types of coronaviruses and viral variants.

21 Oct 2021

COVID-19 vaccination side effects in the USA

A new study described and compared self-reported side effects of three different COVID-19 vaccines administered between March 19 and July 15, 2021, in the United States.

20 Oct 2021

Commonly prescribed medications can make the flu virus more or less active

Although the influenza virus varies a lot from year to year, the flu usually contributes to approximately 1000 deaths a year in Norway.

19 Oct 2021

How did the COVID-19 pandemic impact the circulation of other respiratory viruses in New York City?

Researchers from Columbia University have been investigating the impact of the pandemic on the spread of non-coronavirus respiratory viral infections in New York.

19 Oct 2021

Nasal delivery of single-domain antibodies improves SARS-CoV-2 symptoms in animal model

In a recent study published in the journal PLOS Pathogens, scientists showed that nasal administration of a single-domain antibody (VHH), named K-874A, brought about inhibition of SARS-CoV-2 titers in infected lungs of Syrian hamsters.

19 Oct 2021

Factors contributing to a weak antibody response to the Pfizer COVID-19 vaccine

A new study discusses risk factors for the failure of seroconversion following full vaccination with the COVID-19 Pfizer vaccine.

18 Oct 2021

Surveillance, prevention of COVID-19 and seasonal influenza in Europe

In the northern hemisphere, annual seasonal influenza activity usually causes a high burden of disease during the winter months.

18 Oct 2021

New risk measure can better predict pandemic spread than other models

COVID-19 is not the flu. The disease caused by the novel SARS-CoV-2 virus is more transmissible, and deadlier, than most influenza epidemics we've encountered in our lifetimes, and scientists and physicians are still learning new things about the disease and its long-term effects.

15 Oct 2021

Phase 2 study shows safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine

The results of a phase 2 clinical trial featuring a SARS-CoV-2 recombinant protein vaccine developed by GlaxoSmithKline are reported, demonstrating a favorable immune response amongst both naïve and non-naïve adults with an acceptable safety profile.

15 Oct 2021

Influenza News and Research

Latest Influenza News and Research

A study on the SARS-CoV-2 B.1.620 lineage

People with psychotic disorders at higher risk of hospitalization, death from infectious diseases

Sexually dimorphic placental antibody transfer during SARS-CoV-2 infection

How pregnancy influences SARS-CoV-2 immune response

Compared to influenza, COVID-19 is more likely to cause venous thrombosis

Mapping the molecular gene signatures of respiratory viruses, including SARS-CoV-2

Study shows immune profile heterogeneity amongst healthy adults

Development of a safe and effective COVID-19 nanoparticle vaccine

Hydrogel-based vaccine delivery system evokes antibody response against SARS-CoV-2

Nationwide advertising campaign launches in the UK to urge people to get COVID-19 booster, flu jabs

Comparison of social distancing policies in Denmark and Sweden to combat COVID-19

Duke awarded NIAID funding to develop the next generation of pan-coronavirus vaccines

COVID-19 vaccination side effects in the USA

Commonly prescribed medications can make the flu virus more or less active

How did the COVID-19 pandemic impact the circulation of other respiratory viruses in New York City?

Nasal delivery of single-domain antibodies improves SARS-CoV-2 symptoms in animal model

Factors contributing to a weak antibody response to the Pfizer COVID-19 vaccine

Surveillance, prevention of COVID-19 and seasonal influenza in Europe

New risk measure can better predict pandemic spread than other models

Phase 2 study shows safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Influenza News and Research

Latest Influenza News and Research

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in